3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
12
Small Cell Lung Carcinoma
11
Fallopian Tube Neoplasms
9
Neuroblastoma
6
Neoplasm Metastasis
3
Lung Neoplasms
3
Ganglioneuroblastoma
3
Carcinoma, Ovarian Epithelial
3
Uterine Cervical Neoplasms
2
Sarcoma, Ewing
2
Rhabdoid Tumor
2
Recurrence
2
Leukemia, Myeloid, Acute
2
Glioma
2
Central Nervous System Neoplasms
2
Wilms Tumor
1
Thrombocythemia, Essential
1
SCLC
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pleuropulmonary blastoma
1
Peritoneal Neoplasms
1
Pediatric Brain Tumor
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma, Follicular
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Interventions
ponatinib
4
Methotrexate
4
Cyclophosphamide
4
merphos
3
fludarabine phosphate
3
Whole-Body Irradiation
3
Tacrolimus
2
Rituximab
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Melphalan
2
Cytarabine
2
CT-P10
2
Busulfan
2
venetoclax
1
prednylidene
1
pegylated granulocyte colony-stimulating factor
1
letermovir
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
deltacortene
1
blinatumomab
1
auricularum
1
Vincristine
1
Thiotepa
1
Stem Cell Transplantation
1
Specimen Handling
1
Sirolimus
1
Prednisone
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Accelerated Phase
×
Topotecan
×
90 days
×
Clear all
No trials found.